6505--Carvedilol Tablets (VA-25-00048048)
ID: 36E79725R0028Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/b0337f82bb8148ddb0621e13e6940493/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carvedilol Tablets under solicitation number 36E79725R0028, aimed at ensuring a continuous supply for various federal health care entities, including the Department of Defense and the Bureau of Prisons. The contract will be for one year, with the possibility of four additional one-year extensions, requiring offerors to supply drugs labeled with their unique National Drug Code (NDC) without altering existing labels. This procurement is critical for maintaining the availability of essential medications for veterans and affiliated populations, underscoring the VA's commitment to effective health care delivery. Interested bidders should monitor SAM.gov for updates, with the RFP expected to be issued around March 19, 2025, and responses due by April 2, 2025; inquiries can be directed to Contract Specialist Adrienne Albachiara at adrienne.albachiara@va.gov or by phone at 708-202-9027.

    Point(s) of Contact
    Adrienne AlbachiaraContract Specialist
    (708) 202-9027
    adrienne.albachiara@va.gov
    Files
    Title
    Posted
    36E79725R0028_1.docx
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) for Carvedilol Tablets under solicitation number 36E79725R0028, aimed at ensuring uninterrupted supply for VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will span one year, with four optional one-year extensions. Offerors must supply drugs labeled under their unique National Drug Code (NDC) and cannot replace existing labels on the products. The RFP is set to be electronically issued around March 19, 2025, with a response deadline of April 2, 2025. The anticipated annual requirements include various package sizes and dosages of Carvedilol tablets, with total estimated usage specified for each variant. Interested bidders need to monitor the SAM.gov for updates regarding the solicitation, and inquiries can be directed to the provided contact. This pre-solicitation notice outlines the VA's procurement process for a critical medication, emphasizing the need for a reliable supplier to support federal health care operations, thereby highlighting the commitment to serving veterans and affiliated populations through effective procurement practices.
    Lifecycle
    Title
    Type
    6505--Carvedilol Tablets (VA-25-00048048)
    Currently viewing
    Presolicitation
    Similar Opportunities
    6509--Solifenacin Tabletes (VA-25-00037090)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Solifenacin Tablets, designated as RFP 36E79725R0020. This procurement aims to establish a reliable supply of Solifenacin for the VA, Department of Defense (DoD), and other federal health agencies, with the contract expected to last one year and include four optional renewal periods. Solifenacin is a critical medication used in the treatment of overactive bladder, highlighting the VA's commitment to ensuring access to essential pharmaceuticals for veterans and associated healthcare providers. Interested vendors should monitor SAM.gov for the RFP release, anticipated around March 14, 2025, with proposals due by March 28, 2025; for further inquiries, they may contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    6505--Hydroxychloroquine SO4 Tablets
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a Request for Proposal (RFP) for the procurement of Hydroxychloroquine SO4 Tablets, aimed at ensuring a continuous supply for various federal entities, including the Department of Defense and the Bureau of Prisons. The contract will cover an estimated annual requirement of 163,395 bottles of 100-count and 25,853 bottles of 500-count Hydroxychloroquine tablets, with a contract period of one year and four optional one-year extensions. This procurement is critical for maintaining essential medications within veteran and federal healthcare programs. Interested parties should monitor SAM.gov for updates and direct inquiries to the contracting officer, Chris Carthron, at Christopher.Carthron@va.gov or (708) 786-4980, with submissions due by March 26, 2025.
    6505--Insulin (VA-25-00026482)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of insulin and its derivatives under the solicitation titled "6505--Insulin (VA-25-00026482)." This procurement aims to establish a reliable supply source for pharmaceutical products, specifically focusing on competitive pricing for a base year plus four option years, while ensuring compliance with the Drug Supply Chain Security Act (DSCSA) and good manufacturing practices (cGMP). The contract is critical for maintaining quality healthcare for government participants, and interested offerors must submit their proposals by March 14, 2025, at 2:30 PM Central Standard Time, with all submissions including a 0.5% Cost Recovery Fee. For further inquiries, potential contractors can contact Contract Specialist Billy Fong at Billy.Fong@va.gov.
    Valsartan
    Buyer not available
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Valsartan, a drug used to treat high blood pressure and heart failure. The contract will include Valsartan tablets in various strengths and quantities. It will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The solicitation will be posted on the DLA Bid Board System and beta.SAM.gov, with a projected solicitation date in June 2021. Interested parties should contact Christopher Newman for more information.
    6505--760-25-1-050-0237 -Leavenworth CMOP OM PHARMACEUTICALS -(VA-25-00028391)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a request for proposal (RFP) for the procurement of fourteen specified pharmaceuticals to be delivered to the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) facility in Kansas. This opportunity is exclusively set aside for small businesses under the product service code 6505, which pertains to drugs and biologicals, and requires interested vendors to submit a price schedule, a signed SF1449 cover page, valid state wholesale distributor licenses, and a Buy American Act certificate. The procurement is crucial for ensuring that veterans receive timely access to necessary pharmaceuticals, with the estimated RFP issue date set for March 6, 2025, and a response deadline of March 17, 2025. Interested parties should direct their submissions and inquiries to Contracting Officer Kelley Cunningham at kelley.cunningham@va.gov or by phone at 913-684-0140.
    6505--Rituximab and Biosimilars
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Rituximab 10mg/ml and its biosimilars, aimed at establishing a reliable pharmaceutical supply source for government healthcare facilities. Bidders are required to provide unique National Drug Code (NDC) numbers for their products and include a 0.5% Cost Recovery Fee in their pricing, with the contract covering a base year and four optional subsequent years. This procurement is critical for ensuring consistent product availability and pricing based on estimated annual usage, while adhering to FDA regulations and the Drug Supply Chain Security Act (DSCSA) for safety and traceability. Interested suppliers must submit their proposals by March 11, 2025, at 2:30 PM CT, and can contact Contract Specialist Deborah S Fassl at Deborah.Fassl@va.gov for further information.
    6505--762-25-1-040-0304 -Tucson CMOP PROPRANOLOL -(VA-25-00021631)
    Buyer not available
    The Department of Veterans Affairs is seeking qualified vendors to provide Propranolol for the Tucson Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0137. This procurement focuses on the delivery of high-quality pharmaceutical supplies, emphasizing compliance with shipping standards, packaging, and invoicing requirements, while also supporting small business participation through set-asides for HUBZone and women-owned businesses. The products must meet specific standards, including national drug codes and therapeutic equivalence, with a minimum expiration date of one year from delivery. Interested vendors must submit their quotes by March 14, 2025, at 3:00 PM CT, and can contact Lacie A Nowak at lacie.nowak@va.gov for further details.
    6505--770-25-2-801-0257 -National CMOP F0608 FERROUS SULFATE 324MG EC TAB (VA-25-00044411) 02-28-2025
    Buyer not available
    The Department of Veterans Affairs is soliciting bids for the procurement of Ferrous Sulfate 324mg EC Tablets as part of the National CMOP program, with a contract number of VA-25-00044411. This solicitation requires compliance with the Drug Supply Chain Security Act and mandates that contractors provide specific National Drug Codes for the pharmaceutical products offered. The successful contractor will be responsible for ensuring that all products meet FDA therapeutic equivalence codes and adhere to strict quality assurance standards, including packaging safety and recall procedures. Interested bidders should submit their quotes, including a signed SF 1449 cover page and an Excel pricing schedule, to Contract Specialist Jennifer D. Coleman at jennifer.coleman4@va.gov by the specified deadline of February 28, 2025.
    36C77025Q0138_3 Pharm CLINs Charleston CMOP
    Buyer not available
    The Department of Veterans Affairs is soliciting bids for pharmaceutical supplies under requisition number 36C77025Q0138, specifically for the Charleston Consolidated Mail Outpatient Pharmacy (CMOP). The procurement includes a variety of pharmaceutical products, with requirements for compliance with federal regulations, including packaging and barcoding standards, and mandates that all supplies must have expiration dates exceeding one year from the delivery date. This initiative is crucial for ensuring that the Department can continue to provide quality healthcare services to veterans. Interested vendors must submit their quotes, including necessary documentation, by March 10, 2025, at 3:00 PM Central Time, and can direct inquiries to Lacie A Nowak at lacie.nowak@va.gov.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.